IRADIMED CORPORATION Statistics
Total Valuation
IRMD has a market cap or net worth of $1.26 billion. The enterprise value is $1.21 billion.
| Market Cap | 1.26B |
| Enterprise Value | 1.21B |
Important Dates
The last earnings date was Tuesday, February 10, 2026, before market open.
| Earnings Date | Feb 10, 2026 |
| Ex-Dividend Date | Feb 23, 2026 |
Share Statistics
IRMD has 12.78 million shares outstanding. The number of shares has increased by 0.55% in one year.
| Current Share Class | 12.78M |
| Shares Outstanding | 12.78M |
| Shares Change (YoY) | +0.55% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 35.78% |
| Owned by Institutions (%) | 59.28% |
| Float | 8.15M |
Valuation Ratios
The trailing PE ratio is 56.41 and the forward PE ratio is 51.42.
| PE Ratio | 56.41 |
| Forward PE | 51.42 |
| PS Ratio | 15.06 |
| Forward PS | 13.61 |
| PB Ratio | 13.34 |
| P/TBV Ratio | 13.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 50.58 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 53.86 |
| EV / Sales | 14.45 |
| EV / EBITDA | 44.33 |
| EV / EBIT | 46.30 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.98
| Current Ratio | 7.98 |
| Quick Ratio | 6.37 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 24.78% and return on invested capital (ROIC) is 48.60%.
| Return on Equity (ROE) | 24.78% |
| Return on Assets (ROA) | 15.78% |
| Return on Invested Capital (ROIC) | 48.60% |
| Return on Capital Employed (ROCE) | 26.52% |
| Weighted Average Cost of Capital (WACC) | 10.32% |
| Revenue Per Employee | $523,838 |
| Profits Per Employee | $140,500 |
| Employee Count | 160 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 1.77 |
Taxes
In the past 12 months, IRMD has paid $5.88 million in taxes.
| Income Tax | 5.88M |
| Effective Tax Rate | 20.74% |
Stock Price Statistics
The stock price has increased by +85.91% in the last 52 weeks. The beta is 1.10, so IRMD's price volatility has been higher than the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | +85.91% |
| 50-Day Moving Average | 99.85 |
| 200-Day Moving Average | 78.93 |
| Relative Strength Index (RSI) | 45.29 |
| Average Volume (20 Days) | 66,898 |
Short Selling Information
The latest short interest is 476,088, so 3.72% of the outstanding shares have been sold short.
| Short Interest | 476,088 |
| Short Previous Month | 477,685 |
| Short % of Shares Out | 3.72% |
| Short % of Float | 5.84% |
| Short Ratio (days to cover) | 6.69 |
Income Statement
In the last 12 months, IRMD had revenue of $83.81 million and earned $22.48 million in profits. Earnings per share was $1.75.
| Revenue | 83.81M |
| Gross Profit | 64.32M |
| Operating Income | 26.15M |
| Pretax Income | 28.36M |
| Net Income | 22.48M |
| EBITDA | 27.31M |
| EBIT | 26.15M |
| Earnings Per Share (EPS) | $1.75 |
Balance Sheet
The company has $51.16 million in cash and n/a in debt, with a net cash position of $51.16 million or $4.00 per share.
| Cash & Cash Equivalents | 51.16M |
| Total Debt | n/a |
| Net Cash | 51.16M |
| Net Cash Per Share | $4.00 |
| Equity (Book Value) | 94.62M |
| Book Value Per Share | 7.40 |
| Working Capital | 71.02M |
Cash Flow
| Operating Cash Flow | 24.95M |
| Capital Expenditures | -7.77M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 76.75%, with operating and profit margins of 31.20% and 26.82%.
| Gross Margin | 76.75% |
| Operating Margin | 31.20% |
| Pretax Margin | 33.84% |
| Profit Margin | 26.82% |
| EBITDA Margin | 32.59% |
| EBIT Margin | 31.20% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $0.80, which amounts to a dividend yield of 0.81%.
| Dividend Per Share | $0.80 |
| Dividend Yield | 0.81% |
| Dividend Growth (YoY) | 95.16% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 69.14% |
| Buyback Yield | -0.55% |
| Shareholder Yield | 0.26% |
| Earnings Yield | 1.78% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRMD has an Altman Z-Score of 38.78 and a Piotroski F-Score of 5.
| Altman Z-Score | 38.78 |
| Piotroski F-Score | 5 |